NextVision slides 24% in two days as Fidelity exits and investors ask what comes next
The drone camera maker’s stock is now trading about 30% below the price at which its founders sold $200 million worth of shares in June 2025.
Shares of defense company NextVision plunged another 11.4% on Wednesday, following a 12.7% drop yesterday, bringing the company’s market capitalization to NIS 17.5 billion ($5.7 billion). The stock has now fallen by roughly 50% from its peak in March.
The decline in the shares of the drone camera manufacturer follows Fidelity’s sale of most of its stake in NextVision on Monday in a transaction valued at NIS 1.3 billion ($426 million). The shares were sold at a discount to the market price, just 15 months after Fidelity acquired its stake.
After recording a massive trading volume of NIS 500 million ($164 million) yesterday, the stock saw another NIS 266 million ($87 million) worth of shares change hands today.
Some in the capital market have questioned whether Fidelity actually found buyers for all the shares it sought to sell. To date, the fund has not reported the sale on the Maya disclosure system. Fidelity was previously an interested party in NextVision, holding a 9.94% stake.
Fidelity hired investment bank Goldman Sachs to handle the sale.
“Investors don’t really know what’s going on. If Goldman Sachs is calling institutional investors and enlisting local brokers to do so, it’s a sign things aren’t going well for them. If things were going well, Israelis wouldn’t be getting these calls; only insiders would,” said an executive at a major institutional investment firm.
He added: “NextVision’s founders knew how to sell shares for big money over the past three years. If they had used even a portion of those proceeds to buy the stock back now at a lower price, the bleeding would have stopped.”
There have been no reports to date of the founders purchasing shares.
The company’s founders, Michael Grosman, Chen Golan, and Boris Kipnis, together with Yosef Sandler, who funded the company during its startup phase, have carried out several share sales in recent years. Since the beginning of 2023, they have sold shares worth a total of NIS 1.6 billion ($525 million).
In January 2025, the four sold a 1.5% stake in the company to Harel in an off-market transaction for NIS 425 million ($139 million). In June 2025, they sold additional shares worth $200 million at NIS 272 per share ($89 per share).
The stock currently trades at around NIS 190 ($62), approximately 30% below the price at which the founders sold shares in June. Migdal Insurance, which purchased NIS 200 million ($66 million) worth of shares in that distribution, has suffered a paper loss of approximately 16% on the investment in just two days.
